Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization
Clinical trial NCT02479555 · UNKNOWN
Trial details
- NCT number
- NCT02479555
- Sponsor
- Mercator MedSystems, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2020-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.